Opening Blood-Brain Barrier to Deliver Alzheimer's Drug Shows Promise

(MedPage Today) -- Aducanumab (Aduhelm) infusions combined with focused ultrasound led to lower cerebral amyloid-beta levels in Alzheimer's disease, a proof-of-concept trial showed. The investigational treatment involved creating an opening in...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news